Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Director comp.
Appointed director
Senseonics Holdings, Inc. (SENS) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/10/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
08/10/2023 8-K Quarterly results
Docs: "SENSEONICS HOLDINGS, INC. REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS GERMANTOWN, MD, August 10, 2023 —Senseonics Holdings, Inc. , a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring systems for people with diabetes, today reported financial results for the quarter ended June 30, 2023. Recent Highlights & Accomplishments:"
07/07/2023 SC 13G/A BlackRock Inc. reports a 2.1% stake in SENSEONICS HOLDINGS, INC.
05/31/2023 SD Form SD - Specialized disclosure report:
05/23/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/09/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/09/2023 8-K Quarterly results
Docs: "SENSEONICS HOLDINGS, INC. REPORTS FIRST QUARTER 2023 FINANCIAL"
04/06/2023 ARS Form ARS - Annual Report to Security Holders:
04/06/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/06/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/03/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
Docs: "SENSEONICS HOLDINGS, INC. WARRANT TO PURCHASE COMMON STOCK"
03/20/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
03/15/2023 8-K Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits ...
Docs: "Registration Rights Agreement, by and between Senseonics Holdings, Inc. and PHC Holdings Corporation",
"Securities Purchase Agreement, by and between Senseonics Holdings, Inc. and PHC Holdings Corporation",
"Exchange Agreement, by and between Senseonics Holdings, Inc. and PHC Holdings Corporation",
"Common Stock Purchase Warrant"
03/15/2023 8-K Quarterly results
Docs: "Senseonics Holdings, Inc. Consolidated Balance Sheets December 31, 2022 2021 Assets Current assets: Cash and cash equivalents $ 35,793 $ 33,461 Short term investments, net 108,222 96,445 Accounts receivable, net 127 205 Accounts receivable, net - related parties 2,324 1,768 Inventory, net 7,306 6,316 Prepaid expenses and other current assets 7,428 6,218 Total current assets 161,200 144,413 Option — 239 Deposits and other assets 3,108 1,086 Long term investments, net 12,253 51,882 Property and equipment, net 1,112 1,308 Total assets $ 177,673 $ 198,928 Liabilities and Stockholders’ Deficit Current liabilities: Accounts payable $ 419 $ 1,204 Accrued expenses and other current liabilities 14,616 10,667 Accrued expenses and other current liabilities, related parties 837 3,597 Note payable, cur..."
02/09/2023 SC 13G VANGUARD GROUP INC reports a 5% stake in Senseonics Holdings Inc.
01/30/2023 S-3/A Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
01/10/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
01/10/2023 8-K Other Events  Interactive Data
11/14/2022 8-K Quarterly results
11/08/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/08/2022 8-K Quarterly results
09/01/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/09/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/09/2022 8-K Quarterly results
Docs: "SENSEONICS HOLDINGS, INC. REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS GERMANTOWN, MD, August 9, 2022 —Senseonics Holdings, Inc. , a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring systems for people with diabetes, today reported financial results for the quarter ended June 30, 2022. Recent Highlights & Accomplishments:"
05/26/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
05/26/2022 8-K Quarterly results
05/10/2022 8-K Quarterly results
05/10/2022 10-Q Quarterly Report for the period ended March 31, 2022
04/15/2022 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/15/2022 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/17/2022 424B7 Form 424B7 - Prospectus [Rule 424(b)(7)]:
03/15/2022 8-K Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits  Interactive Data
03/01/2022 8-K Quarterly results
Docs: "Senseonics Holdings, Inc. Condensed Consolidated Balance Sheets Assets Current assets: Cash and cash equivalents $ 33,461 $ 18,005 Restricted cash — 200 Short term investments, net 96,445 — Accounts receivable, net 205 565 Accounts receivable - related parties 1,768 2,421 Inventory, net 6,316 5,281 Prepaid expenses and other current assets 6,218 3,774 Total current assets 144,413 30,246 Option 239 1,886 Deposits and other assets 1,086 2,229 Long term investments, net 51,882 — Property and equipment, net 1,308 1,557 Total assets $ 198,928 $ 35,918 Liabilities and Stockholders’ Deficit Current liabilities: Accounts payable $ 1,204 $ 1,762 Accrued expenses and other current liabilities 10,667 11,674 Accrued expenses and other current liabilities, related parties 3,597 — Term Loans, net 2,926 ..."
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy